2-(Benzyloxy)-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazine

Catalog No. :
ACOKYR594
CAS No. :
2077892-11-4
Molecular Formula :
C17H21BN2O3
Molecular Weight :
312.18

IUPAC Name:2-(Benzyloxy)-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazine

2-(Benzyloxy)-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-(Benzyloxy)-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazine
IUPAC Name2-(Benzyloxy)-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazine
MDL No.MFCD10697464
Molecular FormulaC17H21BN2O3
Molecular Weight312.18
SMILESCC1(C)C(C)(C)OB(C2=CN=CC(OCC3=CC=CC=C3)=N2)O1
InChI KeyFDCUULNRUYCGNT-UHFFFAOYSA-N
Synonym2-(BENZYLOXY)-6-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)PYRAZINE;Pyrazine, 2-(phenylmethoxy)-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-
CAS No.2077892-11-4

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACOKYR594 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACTOBU801 route compound structure diagram
    ACTOBU80173183-34-3 In Stock
  2. Plus
  3. ACPJQL203 route compound structure diagram
    ACPJQL2034774-18-9 In Stock
  4. Then
  5. ACOKYR594 route product structure diagram
    ACOKYR5942077892-11-4
Inquiry

2. ACOKYR594 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACOKYR594 route product structure diagram
    ACOKYR5942077892-11-4
Inquiry

Comments (0)